Published in Circulation on September 11, 2012
Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease. Kidney Int (2016) 0.84
Optimal revascularization for complex coronary artery disease. Nat Rev Cardiol (2013) 0.83
How do We Manage Coronary Artery Disease in Patients with CKD and ESRD? Electrolyte Blood Press (2014) 0.78
Is kidney function affecting the management of myocardial infarction? A retrospective cohort study in patients with normal kidney function, chronic kidney disease stage III-V, and ESRD. Int J Nephrol Renovasc Dis (2016) 0.75
Impact of coronary artery bypass surgery and percutaneous coronary intervention on mortality in patients with chronic kidney disease and on dialysis: A systematic review and meta-analysis. Medicine (Baltimore) (2016) 0.75
Impact of Chronic Kidney Insufficiency on Cardiovascular Outcomes in Patients that Undergo Coronary Revascularization: A Historical Review. ASEAN Heart J (2016) 0.75
Coronary Revascularization in Patients with CKD Stage 5D: Pragmatic Considerations. J Am Soc Nephrol (2016) 0.75
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc (2016) 0.75
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med (2004) 9.13
Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med (2005) 6.53
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol (2004) 4.79
Preoperative renal risk stratification. Circulation (1997) 3.47
Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med (2007) 3.10
Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65
High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol (2005) 2.25
Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl (2003) 2.20
"Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol (2004) 1.94
Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol (2003) 1.42
Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J (2005) 1.39
Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant (1997) 1.28
The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. Am Heart J (2006) 1.13
Severity of chronic kidney disease as a risk factor for operative mortality in nonemergent patients in the California coronary artery bypass graft surgery outcomes reporting program. Am J Cardiol (2008) 0.97
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med (2012) 8.88
Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci U S A (2002) 8.25
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol (2004) 4.79
Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation (2002) 3.74
Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med (2002) 3.71
Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int (2010) 3.34
Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis (2010) 3.11
Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med (2008) 2.99
US Renal Data System 2010 Annual Data Report. Am J Kidney Dis (2011) 2.90
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2005) 2.81
Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians. Diabetes Care (2004) 2.80
Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol (2005) 2.79
US Renal Data System 2013 Annual Data Report. Am J Kidney Dis (2014) 2.68
Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol (2008) 2.65
A prospective, randomized clinical trial to compare the effect of hyperbaric to normobaric hyperoxia on cerebral metabolism, intracranial pressure, and oxygen toxicity in severe traumatic brain injury. J Neurosurg (2010) 2.63
Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients. Kidney Int (2010) 2.57
US Renal Data System 2012 Annual Data Report. Am J Kidney Dis (2013) 2.54
Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation (2013) 2.47
Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int (2005) 2.45
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int (2002) 2.36
Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl (2003) 2.20
Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16
United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis (2009) 2.14
A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data. Am J Kidney Dis (2008) 2.07
Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease. J Invasive Cardiol (2005) 2.06
Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol (2012) 2.03
Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis (2008) 2.01
Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem (2004) 2.01
Assessment of left ventricular function by intensivists using hand-held echocardiography. Chest (2009) 1.93
Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis (2011) 1.92
Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002). Stroke (2006) 1.76
Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2003) 1.70
Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare Part D. Am J Kidney Dis (2011) 1.63
Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study. Kidney Int (2003) 1.58
Improving ascertainment of sudden cardiac death in patients with end stage renal disease. Clin J Am Soc Nephrol (2011) 1.56
Reuse-associated mortality in incident hemodialysis patients in the United States, 2000 to 2001. Am J Kidney Dis (2005) 1.55
Trends in hip fracture rates in US hemodialysis patients, 1993-2010. Am J Kidney Dis (2013) 1.54
Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int (2005) 1.51
Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis (2008) 1.48
The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr (2008) 1.46
Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int (2002) 1.45
Pneumonia in incident dialysis patients--the United States Renal Data System. Nephrol Dial Transplant (2007) 1.43
Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions. Am Heart J (2003) 1.41
Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int (2005) 1.41
Exploratory study of relationship between hospitalized heart failure patients and chronic renal replacement therapy. Nephrol Dial Transplant (2009) 1.40
Kidney disease in cardiology. Nephrol Dial Transplant (2007) 1.38
Scope and design of the Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements (FREEDOM) Study. Am J Kidney Dis (2008) 1.31
Cardiac rehabilitation and survival of dialysis patients after coronary bypass. J Am Soc Nephrol (2006) 1.28
Temporal trends in red blood transfusion among US dialysis patients, 1992-2005. Am J Kidney Dis (2008) 1.24
Anticoagulants in atrial fibrillation patients with chronic kidney disease. Nat Rev Nephrol (2012) 1.23
Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States. Hepatology (2015) 1.20
Incidence of stroke before and after dialysis initiation in older patients. J Am Soc Nephrol (2013) 1.18
The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. J Am Soc Nephrol (2004) 1.18
Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. Adv Ren Replace Ther (2004) 1.16
Warfarin in atrial fibrillation patients with moderate chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.15
Risk-stratified screening for ischemic heart disease in kidney transplant candidates. Transplantation (2005) 1.15
The report of a national conference on the wait list for kidney transplantation. Am J Transplant (2003) 1.14
Improved long-term survival of dialysis patients after near-total parathyroidectomy. J Am Coll Surg (2012) 1.10
Predialysis health, dialysis timing, and outcomes among older United States adults. J Am Soc Nephrol (2013) 1.10
Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J Card Fail (2004) 1.06
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol (2005) 1.05
Hypertension in pediatric long-term hemodialysis patients in the United States. Clin J Am Soc Nephrol (2009) 1.04
Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006. Clin J Am Soc Nephrol (2009) 1.04
Hospital treatment for fluid overload in the Medicare hemodialysis population. Clin J Am Soc Nephrol (2010) 1.04
Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol (2013) 1.03
Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. Am J Kidney Dis (2009) 1.03
Association of provider-patient visit frequency and patient outcomes on hemodialysis. J Am Soc Nephrol (2012) 1.02
Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care. Am J Kidney Dis (2012) 1.02
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. Nephrol Dial Transplant (2012) 1.01
Quantifying a rare disease in administrative data: the example of calciphylaxis. J Gen Intern Med (2014) 1.01
Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol (2012) 1.00
Long-term survival of dialysis patients with bacterial endocarditis undergoing valvular replacement surgery in the United States. Circulation (2013) 1.00
Impact of chronic kidney disease on risk of incident atrial fibrillation and subsequent survival in medicare patients. J Am Heart Assoc (2012) 0.99
The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. J Clin Endocrinol Metab (2013) 0.98
Outcomes of renal transplant and waiting list patients with bacterial endocarditis in the United States. Nephrol Dial Transplant (2008) 0.98
Trends in patient characteristics and first-year medical costs of older incident hemodialysis patients, 1995-2005. Am J Kidney Dis (2010) 0.97
Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload. Clin J Am Soc Nephrol (2007) 0.97
Survival of kidney transplantation patients in the United States after cardiac valve replacement. Circulation (2010) 0.96
Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect? Kidney Int (2004) 0.95
Predialysis systolic BP variability and outcomes in hemodialysis patients. J Am Soc Nephrol (2014) 0.95